Provision of pneumococcal prophylaxis for publicly insured children with sickle cell disease.
about
Pneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and pneumonia with consolidation on x-ray in children under two years of ageDiscontinuation of thyroid hormone treatment among children in the United States with congenital hypothyroidism: findings from health insurance claims dataMedication adherence among pediatric patients with sickle cell disease: a systematic review.Controlling invasive pneumococcal disease: is vaccination of at-risk groups sufficient?Hospitalization for invasive pneumococcal disease in a national sample of children with sickle cell disease before and after PCV7 licensure.Sickle cell disease in California: sociodemographic predictors of emergency department utilizationBurden of influenza-related hospitalizations among children with sickle cell diseaseSickle-cell disease in California: a population-based description of emergency department utilization.Adherence to prophylactic antibiotic guidelines among Medicaid infants with sickle cell disease.Preventive Care Delivery to Young Children With Sickle Cell Disease.A validated measure of adherence to antibiotic prophylaxis in children with sickle cell disease.Adherence to transcranial Doppler screening guidelines among children with sickle cell disease.How we prevent and manage infection in sickle cell disease.Systematic and Meta-Analytic Review: Medication Adherence Among Pediatric Patients With Sickle Cell Disease.Outpatient follow-up and rehospitalizations for sickle cell disease patients.Ambulatory care connections of Medicaid-insured children with sickle cell disease.Burden of illness of patients with allergic asthma versus non-allergic asthma.Incidence of invasive pneumococcal disease among individuals with sickle cell disease before and after the introduction of the pneumococcal conjugate vaccine.
P2860
Q24245934-427A0592-01DD-46DF-AC85-B95C3C9E08D4Q33531343-5DDC750E-D04B-4809-B0C9-443BDCBD2C84Q34567690-CCC7FA82-248A-4EE6-A449-8A34F353D0D4Q34569275-3D9BFCCE-EC6A-4249-81DB-CF35D099146CQ34591762-12CB6029-069E-4AA1-8EF8-B02C9A2FDF33Q35735978-24C24D76-3CE8-412F-9B86-9A7713E724B5Q35768280-6BEC5435-77D3-494D-90F0-B4E18A4FAE58Q35778071-FBEF4195-3D7D-4057-823C-BA2D694F0903Q36680138-EA61B6AE-5546-4B29-9BDA-30B51D6026F7Q36828467-009B7284-F74B-410A-941C-A5AA1DE5CF48Q37007278-FD784ADD-4A94-4F9D-8138-04185D10B0C4Q38022571-234698AC-618E-4946-9376-4B60EFAB877EQ38505129-D9DACB7D-A9DA-44B4-8FDF-B3D0A0F310B9Q38589127-817AA543-4395-464F-BB2E-2E8A2CC140B8Q41982685-409CB198-5C17-481D-BC96-77F19E71D9AFQ45390969-19B1D63A-402B-4B8B-8DAF-A20FDD8DBDAEQ51239172-45523B87-2FD2-4358-864E-FC19054FD6EDQ53236896-69644937-28E6-40FB-B78A-96140F1CCD0F
P2860
Provision of pneumococcal prophylaxis for publicly insured children with sickle cell disease.
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Provision of pneumococcal prop ...... dren with sickle cell disease.
@ast
Provision of pneumococcal prop ...... dren with sickle cell disease.
@en
type
label
Provision of pneumococcal prop ...... dren with sickle cell disease.
@ast
Provision of pneumococcal prop ...... dren with sickle cell disease.
@en
prefLabel
Provision of pneumococcal prop ...... dren with sickle cell disease.
@ast
Provision of pneumococcal prop ...... dren with sickle cell disease.
@en
P2093
P356
P1476
Provision of pneumococcal prop ...... dren with sickle cell disease.
@en
P2093
Colin M Sox
David L DiGiuseppe
Dimitri A Christakis
Thomas D Koepsell
William O Cooper
P304
P356
10.1001/JAMA.290.8.1057
P407
P577
2003-08-01T00:00:00Z